Personalized medicine is changing healthcare by creating treatments specifically designed for each person. And when it comes to leading this new approach, Boston is making huge contributions. As one ...
In November 2024, Elicio shared a pre-print manuscript detailing Elicio’s novel AMP-DNA adjuvants on BioRxIV. The manuscript “Amphiphile-engineered DNA adjuvants stimulate strong type I IFN production ...